Literature DB >> 24172773

Rhinocerebral mucormycosis in a patient with type 1 diabetes presenting as toothache: a case report from Himalayan region of India.

Vikram Singh1, Mridu Singh, Chitra Joshi, Jyoti Sangwan.   

Abstract

Mucormycosis is an angioinvasive infection caused by ubiquitous filamentous fungi of the order Mucorales. It is a rapidly progressive fatal infection mostly reported in susceptible individuals, such as those with poorly controlled diabetes or those with defects in phagocytic function. Rhinocerebral mucormycosis is the most common type of mucormycosis in diabetic patients. This case report describes a 17-year-old girl with type 1 diabetes mellitus presenting with rhinocerebral mucormycosis. The patient presented with a history of toothache and facial pain with oedema of left half of face, periorbital oedema and depressed conciousness. She had hyperglycaemia with diabetic ketoacidosis and rapidly developed hemiparesis progressing to quadriparesis and died within 3 days of admission. The current report emphasises the importance of having a high index of suspicion when dealing with patients with diabetes presenting with facial pain or cellulitis and prompt initiation of medical therapy along with surgical debridement for control of rhinocerebral mucormycosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24172773      PMCID: PMC3822077          DOI: 10.1136/bcr-2013-200811

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Cutaneous zygomycosis : major concerns.

Authors:  Arunaloke Chakrabarti
Journal:  Indian J Med Res       Date:  2010-06       Impact factor: 2.375

Review 2.  Rhinocerebral mucormycosis: an update.

Authors:  A Mallis; S N Mastronikolis; S S Naxakis; A T Papadas
Journal:  Eur Rev Med Pharmacol Sci       Date:  2010-11       Impact factor: 3.507

3.  Rhinocerebral mucormycosis: perineural spread via the trigeminal nerve.

Authors:  Sebnem Orguc; Ali Vefa Yücetürk; M Akif Demir; Cihan Goktan
Journal:  J Clin Neurosci       Date:  2005-05       Impact factor: 1.961

Review 4.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

5.  Rhinocerebral mucormycosis: pathways of spread.

Authors:  Seid Mousa Sadr Hosseini; Peyman Borghei
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-05-13       Impact factor: 2.503

Review 6.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

7.  Mucormycosis in immunochallenged patients.

Authors:  Jane Pak; Veronica T Tucci; Albert L Vincent; Ramon L Sandin; John N Greene
Journal:  J Emerg Trauma Shock       Date:  2008-07

Review 8.  Survival factors in rhino-orbital-cerebral mucormycosis.

Authors:  R A Yohai; J D Bullock; A A Aziz; R J Markert
Journal:  Surv Ophthalmol       Date:  1994 Jul-Aug       Impact factor: 6.048

9.  Invasive zygomycosis in India: experience in a tertiary care hospital.

Authors:  A Chakrabarti; S S Chatterjee; A Das; N Panda; M R Shivaprakash; A Kaur; S C Varma; S Singhi; A Bhansali; V Sakhuja
Journal:  Postgrad Med J       Date:  2009-11       Impact factor: 2.401

10.  Clinical signs of orbital ischemia in rhino-orbitocerebral mucormycosis.

Authors:  N P Bodenstein; W A McIntosh; A C Vlantis; A C Urquhart
Journal:  Laryngoscope       Date:  1993-12       Impact factor: 3.325

View more
  2 in total

1.  Rhino-orbital-cerebral mucormycosis in times of COVID-19: A neurosurgical experience.

Authors:  Hershdeep Singh; Sanjeev Dua; Amitabh Goel; Anil Dhar; Vikram Bhadauria; Amit Garg; Vikrant Katyar; Sumit Sharma; Aditi Shukla
Journal:  Surg Neurol Int       Date:  2021-10-25

2.  Surgical management of post-COVID invasive rhino-orbito-cerebral mucormycosis and its outcomes: Role of neurosurgeons in a tertiary care center.

Authors:  Anand Kumar Das; Suraj Kant Mani; Saraj Kumar Singh
Journal:  Surg Neurol Int       Date:  2022-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.